Original Research

Published on 08 Jan 2024

Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)

in Molecular Pathology

Claudia Theys
Tineke Vanderhaeghen
Evelien Van Dijck
Cedric Peleman
Anne Scheepers
Joe Ibrahim
Ligia Mateiu
Steven Timmermans
Tom Vanden Berghe
Sven M. Francque

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2023.1283170

2,521 views

Editorial

Published on 26 Jun 2023

Editorial: Biomarkers to evaluate rare diseases

in Molecular Pathology

Bridget E. Bax
Dario Pacitti

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2023.1237089

1,352 views

Brief Research Report

Published on 22 Feb 2023

MCM10 expression is linked to cervical cancer aggressiveness

in Molecular Pathology

Sumayyah M. Q. Ahmed
Suparna Laha
Ranajit Das
Mariam Anjum Ifthikar
Shankar Prasad Das

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2023.1009903

1,830 views
1 citation

Hypothesis and Theory

Published on 04 Jan 2023

Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms

in Molecular Pathology

Stephan Brock
David B. Jackson
Theodoros G. Soldatos
Klaus Hornischer
Anne Schäfer
Francesca Diella
Maximilian Y. Emmert
Simon P. Hoerstrup

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2022.1035290

4,218 views
3 citations

Review

Published on 26 Sep 2022

The IRE1α pathway in glomerular diseases: The unfolded protein response and beyond

in Molecular Pathology

José R. Navarro-Betancourt
Andrey V. Cybulsky

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2022.971247

2,132 views
2 citations

Review

Published on 08 Jul 2022

A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes

in Molecular Pathology

Henry H. Nguyen
Marvin J. Fritzler
Mark G. Swain

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2022.914505

2,366 views
2 citations

Original Research

Published on 15 Mar 2022

Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis

in Molecular Pathology

Ksenija Bernau
Melissa Skibba
Jonathan P. Leet
Sierra Furey
Carson Gehl
Yi Li
Jia Zhou
Nathan Sandbo
Allan R. Brasier

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2022.842558

3,083 views
9 citations

Review

Published on 16 Nov 2021

The Molecular Effects of Dietary Acid Load on Metabolic Disease (The Cellular PasaDoble: The Fast-Paced Dance of pH Regulation)

in Molecular Pathology

Morgan Williamson
Naima Moustaid-Moussa
Lauren Gollahon

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2021.777088

6,508 views
9 citations

Navigation group

Articles

Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)

Editorial: Biomarkers to evaluate rare diseases

MCM10 expression is linked to cervical cancer aggressiveness

Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms

The IRE1α pathway in glomerular diseases: The unfolded protein response and beyond

A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes

Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis

The Molecular Effects of Dietary Acid Load on Metabolic Disease (The Cellular PasaDoble: The Fast-Paced Dance of pH Regulation)